STOCK TITAN

[SCHEDULE 13G] Erasca, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Erasca, Inc. received Schedule 13G disclosures showing that Suvretta Capital Management, LLC and Aaron Cowen report beneficial ownership of 14,502,004 shares, equal to 5.1% of Erasca's common stock. Averill Master Fund, Ltd. reports 12,717,004 shares, or 4.5%. The filings show shared voting and dispositive power for those amounts and state the securities are held in the ordinary course of business and not to change or influence control. The document references Exhibits A and B and carries signatures dated 08/13/2025 with the report tied to the 06/30/2025 event.

Erasca, Inc. ha ricevuto le comunicazioni Schedule 13G che indicano che Suvretta Capital Management, LLC e Aaron Cowen dichiarano la proprietà beneficiaria di 14.502.004 azioni, pari al 5,1% del capitale ordinario di Erasca. Averill Master Fund, Ltd. dichiara 12.717.004 azioni, ovvero il 4,5%. Le dichiarazioni riportano la condivisa facoltà di voto e di disposizione per tali quantità e precisano che i titoli sono detenuti nell'ordinario svolgimento dell'attività aziendale e non al fine di modificare o influenzare il controllo. Il documento cita gli Allegati A e B e riporta firme in data 08/13/2025, con il rapporto riferito all'evento del 06/30/2025.

Erasca, Inc. recibió divulgaciones Schedule 13G que muestran que Suvretta Capital Management, LLC y Aaron Cowen informan la propiedad beneficiaria de 14.502.004 acciones, equivalentes al 5,1% del capital social ordinario de Erasca. Averill Master Fund, Ltd. informa 12.717.004 acciones, o el 4,5%. Las presentaciones indican poder compartido de voto y de disposición sobre esas cantidades y afirman que los valores se mantienen en el curso ordinario del negocio y no con la finalidad de cambiar o influir en el control. El documento hace referencia a los Anexos A y B y contiene firmas fechadas 08/13/2025, vinculando el informe al evento del 06/30/2025.

Erasca, Inc.는 Schedule 13G 공시를 접수했으며, Suvretta Capital Management, LLC와 Aaron Cowen이 Erasca 보통주의 14,502,004주를 실질 보유하고 있어 전체의 5.1%에 해당한다고 보고했습니다. Averill Master Fund, Ltd.는 12,717,004주, 즉 4.5%를 보고했습니다. 제출 서류에는 해당 수량에 대해 공동 의결권 및 처분권이 있음을 기재하고 있으며, 증권은 영업상의 관행으로 보유되고 지배권을 변경하거나 영향을 주려는 목적이 아님을 명시합니다. 문서는 부속서 A와 B를 언급하고 서명일을 08/13/2025로 기재했으며, 보고서는 06/30/2025 사건과 관련되어 있습니다.

Erasca, Inc. a reçu des déclarations Schedule 13G montrant que Suvretta Capital Management, LLC et Aaron Cowen déclarent la propriété bénéficiaire de 14 502 004 actions, soit 5,1% du capital ordinaire d'Erasca. Averill Master Fund, Ltd. déclare 12 717 004 actions, soit 4,5%. Les dépôts indiquent une détention conjointe du pouvoir de vote et du pouvoir de disposition pour ces montants et précisent que les titres sont détenus dans le cours normal des affaires et n'ont pas pour but de modifier ou d'influencer le contrôle. Le document renvoie aux Annexes A et B et porte des signatures datées 08/13/2025, le rapport étant lié à l'événement du 06/30/2025.

Erasca, Inc. erhielt Schedule 13G-Meldungen, wonach Suvretta Capital Management, LLC und Aaron Cowen wirtschaftliches Eigentum an 14.502.004 Aktien melden, was 5,1% des Stammkapitals von Erasca entspricht. Averill Master Fund, Ltd. meldet 12.717.004 Aktien bzw. 4,5%. Die Einreichungen weisen für diese Beträge auf gemeinsame Stimm- und Verfügungsrechte hin und geben an, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht dazu dienen, die Kontrolle zu ändern oder zu beeinflussen. Das Dokument verweist auf Anlagen A und B und trägt Unterschriften datiert 08/13/2025, wobei der Bericht auf das Ereignis vom 06/30/2025 Bezug nimmt.

Positive
  • Suvretta Capital reports 14,502,004 shares (5.1% of Erasca common stock)
  • Averill Master Fund reports 12,717,004 shares (4.5% of class)
Negative
  • None.

Insights

TL;DR: Institutional positions disclosed — Suvretta and Aaron Cowen report a 5.1% passive stake; Averill holds 4.5%.

The filing quantifies ownership: Suvretta Capital Management and Aaron Cowen each report 14,502,004 shares (5.1%), while Averill Master Fund reports 12,717,004 shares (4.5%). All reported shares show shared voting and dispositive power. The statement is filed on Schedule 13G and includes a certification that the holdings are held in the ordinary course of business and not for the purpose of changing control, which signals passive investor status rather than an active control intent.

TL;DR: Schedule 13G filing indicates passive ownership with shared voting power disclosed and explicit certification of no control intent.

The document identifies reporting persons, their places of organization, and precise share counts and percentages. Item 6 clarifies the Suvretta-reported securities are directly owned by advisory clients and that none of those clients individually exceed 5% of the class, while Suvretta as adviser reports the aggregate 5.1% position. The filing includes Exhibits A and B (joint filing agreement and control-person identification) and signatures by authorized signatories, reinforcing procedural completeness.

Erasca, Inc. ha ricevuto le comunicazioni Schedule 13G che indicano che Suvretta Capital Management, LLC e Aaron Cowen dichiarano la proprietà beneficiaria di 14.502.004 azioni, pari al 5,1% del capitale ordinario di Erasca. Averill Master Fund, Ltd. dichiara 12.717.004 azioni, ovvero il 4,5%. Le dichiarazioni riportano la condivisa facoltà di voto e di disposizione per tali quantità e precisano che i titoli sono detenuti nell'ordinario svolgimento dell'attività aziendale e non al fine di modificare o influenzare il controllo. Il documento cita gli Allegati A e B e riporta firme in data 08/13/2025, con il rapporto riferito all'evento del 06/30/2025.

Erasca, Inc. recibió divulgaciones Schedule 13G que muestran que Suvretta Capital Management, LLC y Aaron Cowen informan la propiedad beneficiaria de 14.502.004 acciones, equivalentes al 5,1% del capital social ordinario de Erasca. Averill Master Fund, Ltd. informa 12.717.004 acciones, o el 4,5%. Las presentaciones indican poder compartido de voto y de disposición sobre esas cantidades y afirman que los valores se mantienen en el curso ordinario del negocio y no con la finalidad de cambiar o influir en el control. El documento hace referencia a los Anexos A y B y contiene firmas fechadas 08/13/2025, vinculando el informe al evento del 06/30/2025.

Erasca, Inc.는 Schedule 13G 공시를 접수했으며, Suvretta Capital Management, LLC와 Aaron Cowen이 Erasca 보통주의 14,502,004주를 실질 보유하고 있어 전체의 5.1%에 해당한다고 보고했습니다. Averill Master Fund, Ltd.는 12,717,004주, 즉 4.5%를 보고했습니다. 제출 서류에는 해당 수량에 대해 공동 의결권 및 처분권이 있음을 기재하고 있으며, 증권은 영업상의 관행으로 보유되고 지배권을 변경하거나 영향을 주려는 목적이 아님을 명시합니다. 문서는 부속서 A와 B를 언급하고 서명일을 08/13/2025로 기재했으며, 보고서는 06/30/2025 사건과 관련되어 있습니다.

Erasca, Inc. a reçu des déclarations Schedule 13G montrant que Suvretta Capital Management, LLC et Aaron Cowen déclarent la propriété bénéficiaire de 14 502 004 actions, soit 5,1% du capital ordinaire d'Erasca. Averill Master Fund, Ltd. déclare 12 717 004 actions, soit 4,5%. Les dépôts indiquent une détention conjointe du pouvoir de vote et du pouvoir de disposition pour ces montants et précisent que les titres sont détenus dans le cours normal des affaires et n'ont pas pour but de modifier ou d'influencer le contrôle. Le document renvoie aux Annexes A et B et porte des signatures datées 08/13/2025, le rapport étant lié à l'événement du 06/30/2025.

Erasca, Inc. erhielt Schedule 13G-Meldungen, wonach Suvretta Capital Management, LLC und Aaron Cowen wirtschaftliches Eigentum an 14.502.004 Aktien melden, was 5,1% des Stammkapitals von Erasca entspricht. Averill Master Fund, Ltd. meldet 12.717.004 Aktien bzw. 4,5%. Die Einreichungen weisen für diese Beträge auf gemeinsame Stimm- und Verfügungsrechte hin und geben an, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht dazu dienen, die Kontrolle zu ändern oder zu beeinflussen. Das Dokument verweist auf Anlagen A und B und trägt Unterschriften datiert 08/13/2025, wobei der Bericht auf das Ereignis vom 06/30/2025 Bezug nimmt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Suvretta Capital Management, LLC
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson/General Counsel and Chief Compliance Officer
Date:08/13/2025
Averill Master Fund, Ltd.
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson/Authorized Signatory
Date:08/13/2025
Aaron Cowen
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:08/13/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]

FAQ

What stake did Suvretta Capital report in Erasca (ERAS)?

14,502,004 shares, representing 5.1% of Erasca's common stock according to the Schedule 13G.

What stake did Averill Master Fund report in Erasca (ERAS)?

12,717,004 shares, representing 4.5% of Erasca's common stock as disclosed in the filing.

Does the filing indicate an intent to influence control of Erasca?

No. The filing includes a certification stating the securities are held in the ordinary course of business and were not acquired to change or influence control.

Who are the reporting persons on the Schedule 13G for ERAS?

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen are listed as reporting persons.

What voting and dispositive power is reported?

The filing shows 0 sole voting/dispositive power and shared voting and shared dispositive power of 14,502,004 for Suvretta and Aaron Cowen and 12,717,004 for Averill.
Erasca, Inc.

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Latest SEC Filings

ERAS Stock Data

459.55M
227.59M
11.69%
84.29%
6.98%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO